Company News
Beta Drugs Completes 66.09% Nivian Lifesciences Acquisition
Beta Drugs Ltd completed acquisition of 66.09% equity stake in Nivian Lifesciences Private Limited, making it a subsidiary.
64.26% shares were transferred by April 30, 2026, with remaining shares tran
